BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatment

被引：3
|
作者：
Niederer, Fabienne [1 ]
Scherer, Almut [2 ]
Kyburz, Diego [3 ]
Gay, Renate E. [1 ]
Gay, Steffen [1 ]
Michel, Beat A. [3 ]
Ciurea, Adrian [3 ]
机构：
[1] Univ Zurich Hosp, Ctr Expt Rheumatol, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Zurich, Switzerland
[3] Univ Zurich Hosp, Dept Rheumatol, CH-8091 Zurich, Switzerland
来源：
JOINT BONE SPINE | 2013年 / 80卷 / 04期
关键词：
Ankylosing spondylitis; BAFF; BLyS; Anti-tumor necrosis factor treatment; RHEUMATOID-ARTHRITIS; DISEASES; THERAPY;
D O I：
10.1016/j.jbspin.2012.10.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：433 / 434
页数：2
相关论文
共 50 条
  • [21] Anti-tumor necrosis factor treatment in ankylosing spondylitis may not relate to poor prognosis in COVID-19
    Sen, Nesrin
    Tezcan, Mehmet Engin
    [J]. ARCHIVES OF RHEUMATOLOGY, 2021, 36 (01) : 142 - 143
  • [22] Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α
    Gorman, JD
    Sack, KE
    Davis, JC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (18): : 1349 - 1356
  • [23] The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis
    Tugsal, Handan Yarkan
    Kenar, Gokce
    Can, Gercek
    Capar, Sedat
    Zengin, Berrin
    Akar, Servet
    Dalkilic, Ediz
    Senel, Soner
    Koca, Suleyman Serdar
    Goker, Berna
    Yazici, Ayten
    Inanc, Nevsun
    Ellidokuz, Hulya
    Akkoc, Nurullah
    Onen, Fatos
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2023, 53 (04) : 970 - 978
  • [24] Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
    Carla GS Saad
    Ana CM Ribeiro
    Julio CB Moraes
    Liliam Takayama
    Celio R Goncalves
    Marcelo B Rodrigues
    Ricardo M de Oliveira
    Clovis A Silva
    Eloisa Bonfa
    Rosa MR Pereira
    [J]. Arthritis Research & Therapy, 14
  • [25] The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: a pilot study
    J S Oh
    H-M Heo
    Y-G Kim
    S G Lee
    C-K Lee
    B Yoo
    [J]. International Journal of Impotence Research, 2009, 21 : 372 - 375
  • [26] Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
    Saad, Carla G. S.
    Ribeiro, Ana C. M.
    Moraes, Julio C. B.
    Takayama, Liliam
    Goncalves, Celio R.
    Rodrigues, Marcelo B.
    de Oliveira, Ricardo M.
    Silva, Clovis A.
    Bonfa, Eloisa
    Pereira, Rosa M. R.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2012, 14 (05)
  • [27] Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
    Martin Rudwaleit
    Filip Van den Bosch
    Martina Kron
    Sonja Kary
    Hartmut Kupper
    [J]. Arthritis Research & Therapy, 12
  • [28] The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: a pilot study
    Oh, J. S.
    Heo, H-M
    Kim, Y-G
    Lee, S. G.
    Lee, C-K
    Yoo, B.
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2009, 21 (06) : 372 - 375
  • [29] Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
    Rudwaleit, Martin
    Van den Bosch, Filip
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    [J]. ARTHRITIS RESEARCH & THERAPY, 2010, 12 (03)
  • [30] The Burden of Ankylosing Spondylitis and the Cost-Effectiveness of Anti-Tumor Necrosis Factor α Agents in Romania
    Ancuta, Ioan
    Codreanu, Catalin
    Ionescu, Ruxandra
    Parvu, Magda
    Bojinca, Mihai
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S596 - S597
12345